Sol-Gel Technologies Ltd. SEC filings SLGL
Sol-Gel Technologies Ltd. has 329 filings in SEC EDGAR's recent list, going back to Sep 28, 2016. Its latest annual report, Form 20-F, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 6, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Mar 24, 2026 | — |
| POS AM | Filing | Mar 19, 2026 | — |
| POS AM | Filing | Aug 15, 2025 | — |
| 424B3 | Prospectus | May 23, 2025 | — |
| 424B3 | Prospectus | May 8, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 29, 2025 | — |
| S-8 | Employee stock plan registration | Apr 29, 2025 | — |
| POS AM | Filing | Apr 29, 2025 | — |
| 424B3 | Prospectus | Nov 15, 2024 | — |
| 424B3 | Prospectus | Aug 19, 2024 | — |
| 424B3 | Prospectus | May 20, 2024 | — |
| 424B3 | Prospectus | Apr 4, 2024 | — |
| POS AM | Filing | Mar 20, 2024 | — |
| 424B3 | Prospectus | Nov 9, 2023 | — |
| 424B3 | Prospectus | Aug 10, 2023 | — |
| 424B3 | Prospectus | May 12, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Mar 10, 2023 | — |
| S-8 | Employee stock plan registration | Mar 10, 2023 | — |
| 424B5 | Prospectus supplement | Jan 27, 2023 | — |
| 424B5 | Prospectus supplement | Apr 19, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 7, 2022 | — |
| 424B5 | Prospectus supplement | Feb 14, 2020 | — |
| 424B5 | Prospectus supplement | Jan 10, 2020 | — |
| 424B5 | Prospectus supplement | Aug 8, 2019 | — |
| 424B5 | Prospectus supplement | May 31, 2019 | — |
| F-3/A | Filing | Apr 10, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 28, 2019 | — |
| S-8 | Employee stock plan registration | Mar 26, 2018 | — |
| 424B4 | Prospectus | Feb 2, 2018 | — |
| FWP | Free writing prospectus | Jan 30, 2018 | — |
| F-1/A | Amendment no. 5 to form f-1 | Jan 30, 2018 | — |
| F-1/A | Amendment no. 4 to form f-1 | Jan 23, 2018 | — |
| F-1/A | Amendment no. 3 to form f-1 | Dec 29, 2017 | — |
| F-1/A | Amendment no. 2 to form f-1 | Sep 20, 2017 | — |
| F-1/A | Amendment no. 1 to form f-1 | Sep 6, 2017 | — |
| F-1 | Registration statement (foreign issuer) | Aug 29, 2017 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SLGL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Ness Ziona
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1684693
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.